ID   OXDA_HUMAN              Reviewed;         347 AA.
AC   P14920; B2R7I5; Q16758; Q8N6R2;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2002, sequence version 3.
DT   10-MAY-2017, entry version 170.
DE   RecName: Full=D-amino-acid oxidase;
DE            Short=DAAO;
DE            Short=DAMOX;
DE            Short=DAO;
DE            EC=1.4.3.3;
GN   Name=DAO; Synonyms=DAMOX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=2901986; DOI=10.1016/0014-5793(88)80252-7;
RA   Momoi K., Fukui K., Watanabe F., Miyake Y.;
RT   "Molecular cloning and sequence analysis of cDNA encoding human kidney
RT   D-amino acid oxidase.";
RL   FEBS Lett. 238:180-184(1988).
RN   [2]
RP   SEQUENCE REVISION.
RA   Momoi K.;
RL   Submitted (SEP-1990) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Colon, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-65.
RX   PubMed=1356107;
RA   Fukui K., Miyake Y.;
RT   "Molecular cloning and chromosomal localization of a human gene
RT   encoding D-amino-acid oxidase.";
RL   J. Biol. Chem. 267:18631-18638(1992).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH FAD AND THE
RP   INHIBITOR BENZOATE, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   AND SUBUNIT.
RX   PubMed=17088322; DOI=10.1110/ps.062421606;
RA   Kawazoe T., Tsuge H., Pilone M.S., Fukui K.;
RT   "Crystal structure of human D-amino acid oxidase: context-dependent
RT   variability of the backbone conformation of the VAAGL hydrophobic
RT   stretch located at the si-face of the flavin ring.";
RL   Protein Sci. 15:2708-2717(2006).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEXES WITH FAD AND
RP   IMINO-SERINE; IMINO-DOPA AND O-AMINOBENZOATE, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND FUNCTION.
RX   PubMed=17303072; DOI=10.1016/j.bbrc.2007.01.181;
RA   Kawazoe T., Tsuge H., Imagawa T., Aki K., Kuramitsu S., Fukui K.;
RT   "Structural basis of D-DOPA oxidation by D-amino acid oxidase:
RT   alternative pathway for dopamine biosynthesis.";
RL   Biochem. Biophys. Res. Commun. 355:385-391(2007).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.49 ANGSTROMS) IN COMPLEX WITH FAD AND
RP   SYNTHETIC INHIBITOR.
RX   PubMed=18455394; DOI=10.1016/j.bmcl.2008.04.020;
RA   Sparey T., Abeywickrema P., Almond S., Brandon N., Byrne N.,
RA   Campbell A., Hutson P.H., Jacobson M., Jones B., Munshi S.,
RA   Pascarella D., Pike A., Prasad G.S., Sachs N., Sakatis M., Sardana V.,
RA   Venkatraman S., Young M.B.;
RT   "The discovery of fused pyrrole carboxylic acids as novel, potent D-
RT   amino acid oxidase (DAO) inhibitors.";
RL   Bioorg. Med. Chem. Lett. 18:3386-3391(2008).
CC   -!- FUNCTION: Regulates the level of the neuromodulator D-serine in
CC       the brain. Has high activity towards D-DOPA and contributes to
CC       dopamine synthesis. Could act as a detoxifying agent which removes
CC       D-amino acids accumulated during aging. Acts on a variety of D-
CC       amino acids with a preference for those having small hydrophobic
CC       side chains followed by those bearing polar, aromatic, and basic
CC       groups. Does not act on acidic amino acids.
CC       {ECO:0000269|PubMed:17303072}.
CC   -!- CATALYTIC ACTIVITY: A D-amino acid + H(2)O + O(2) = a 2-oxo acid +
CC       NH(3) + H(2)O(2). {ECO:0000269|PubMed:17088322}.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.6 mM for D-serine {ECO:0000269|PubMed:17088322,
CC         ECO:0000269|PubMed:17303072};
CC         KM=1.7 mM for D-proline {ECO:0000269|PubMed:17088322,
CC         ECO:0000269|PubMed:17303072};
CC         KM=1.1 mM for D-tyrosine {ECO:0000269|PubMed:17088322,
CC         ECO:0000269|PubMed:17303072};
CC         KM=1.5 mM for D-DOPA {ECO:0000269|PubMed:17088322,
CC         ECO:0000269|PubMed:17303072};
CC         KM=1.2 mM for D-phenylalanine {ECO:0000269|PubMed:17088322,
CC         ECO:0000269|PubMed:17303072};
CC         KM=0.9 mM for D-alanine {ECO:0000269|PubMed:17088322,
CC         ECO:0000269|PubMed:17303072};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:17088322,
CC       ECO:0000269|PubMed:18455394}.
CC   -!- INTERACTION:
CC       O43741:PRKAB2; NbExp=4; IntAct=EBI-3908043, EBI-1053424;
CC   -!- SUBCELLULAR LOCATION: Peroxisome.
CC   -!- SIMILARITY: Belongs to the DAMOX/DASOX family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X13227; CAA31614.1; -; mRNA.
DR   EMBL; AK312995; BAG35832.1; -; mRNA.
DR   EMBL; CH471054; EAW97837.1; -; Genomic_DNA.
DR   EMBL; BC029057; AAH29057.1; -; mRNA.
DR   EMBL; BC074770; AAH74770.1; -; mRNA.
DR   EMBL; D11370; BAA20974.1; -; Genomic_DNA.
DR   CCDS; CCDS9122.1; -.
DR   PIR; S01340; S01340.
DR   RefSeq; NP_001908.3; NM_001917.4.
DR   RefSeq; XP_011536306.1; XM_011538004.2.
DR   RefSeq; XP_011536307.1; XM_011538005.2.
DR   UniGene; Hs.113227; -.
DR   PDB; 2DU8; X-ray; 2.50 A; A/B/G/J=1-347.
DR   PDB; 2E48; X-ray; 2.90 A; A/B/C/D=1-347.
DR   PDB; 2E49; X-ray; 3.20 A; A/B/C/D=1-347.
DR   PDB; 2E4A; X-ray; 2.60 A; A/B/C/D=1-347.
DR   PDB; 2E82; X-ray; 2.70 A; A/B/C/D=1-347.
DR   PDB; 2GNZ; Model; -; A=1-339.
DR   PDB; 3CUK; X-ray; 2.49 A; A/B/C/D=1-347.
DR   PDB; 3G3E; X-ray; 2.20 A; A/B/C/D=1-347.
DR   PDB; 3W4I; X-ray; 2.50 A; A/B/C/D=1-347.
DR   PDB; 3W4J; X-ray; 2.74 A; A/B/C/D=1-347.
DR   PDB; 3W4K; X-ray; 2.86 A; A/B/C/D=1-347.
DR   PDB; 3ZNN; X-ray; 1.90 A; A/B=1-347.
DR   PDB; 3ZNO; X-ray; 2.30 A; A/B=1-347.
DR   PDB; 3ZNP; X-ray; 2.40 A; A/B=1-347.
DR   PDB; 3ZNQ; X-ray; 2.75 A; A/B=1-347.
DR   PDB; 4QFC; X-ray; 2.40 A; A/B=1-347.
DR   PDB; 4QFD; X-ray; 2.85 A; A/B=1-347.
DR   PDBsum; 2DU8; -.
DR   PDBsum; 2E48; -.
DR   PDBsum; 2E49; -.
DR   PDBsum; 2E4A; -.
DR   PDBsum; 2E82; -.
DR   PDBsum; 2GNZ; -.
DR   PDBsum; 3CUK; -.
DR   PDBsum; 3G3E; -.
DR   PDBsum; 3W4I; -.
DR   PDBsum; 3W4J; -.
DR   PDBsum; 3W4K; -.
DR   PDBsum; 3ZNN; -.
DR   PDBsum; 3ZNO; -.
DR   PDBsum; 3ZNP; -.
DR   PDBsum; 3ZNQ; -.
DR   PDBsum; 4QFC; -.
DR   PDBsum; 4QFD; -.
DR   ProteinModelPortal; P14920; -.
DR   SMR; P14920; -.
DR   BioGrid; 107980; 6.
DR   IntAct; P14920; 2.
DR   STRING; 9606.ENSP00000228476; -.
DR   BindingDB; P14920; -.
DR   ChEMBL; CHEMBL5485; -.
DR   DrugBank; DB04166; 2-Aminobenzoic Acid.
DR   DrugBank; DB03793; Benzoic Acid.
DR   DrugBank; DB03225; D-Tryptophan.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB03531; Flavin-Adenine Dinucleotide-N5-Isobutyl Ketone.
DR   DrugBank; DB02988; Imino-Tryptophan.
DR   iPTMnet; P14920; -.
DR   PhosphoSitePlus; P14920; -.
DR   BioMuta; DAO; -.
DR   DMDM; 25453448; -.
DR   PaxDb; P14920; -.
DR   PeptideAtlas; P14920; -.
DR   PRIDE; P14920; -.
DR   TopDownProteomics; P14920; -.
DR   Ensembl; ENST00000228476; ENSP00000228476; ENSG00000110887.
DR   GeneID; 1610; -.
DR   KEGG; hsa:1610; -.
DR   UCSC; uc001tnr.5; human.
DR   CTD; 1610; -.
DR   DisGeNET; 1610; -.
DR   GeneCards; DAO; -.
DR   HGNC; HGNC:2671; DAO.
DR   HPA; HPA038653; -.
DR   HPA; HPA038654; -.
DR   MalaCards; DAO; -.
DR   MIM; 124050; gene.
DR   neXtProt; NX_P14920; -.
DR   OpenTargets; ENSG00000110887; -.
DR   Orphanet; 803; Amyotrophic lateral sclerosis.
DR   PharmGKB; PA27139; -.
DR   eggNOG; KOG3923; Eukaryota.
DR   eggNOG; COG0665; LUCA.
DR   GeneTree; ENSGT00390000018635; -.
DR   HOGENOM; HOG000046303; -.
DR   HOVERGEN; HBG003493; -.
DR   InParanoid; P14920; -.
DR   KO; K00273; -.
DR   OMA; IHEHYHS; -.
DR   OrthoDB; EOG091G0G0Y; -.
DR   PhylomeDB; P14920; -.
DR   TreeFam; TF313887; -.
DR   BioCyc; MetaCyc:HS03351-MONOMER; -.
DR   BRENDA; 1.4.3.3; 2681.
DR   Reactome; R-HSA-389661; Glyoxylate metabolism and glycine degradation.
DR   ChiTaRS; DAO; human.
DR   EvolutionaryTrace; P14920; -.
DR   GenomeRNAi; 1610; -.
DR   PRO; PR:P14920; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000110887; -.
DR   CleanEx; HS_DAO; -.
DR   ExpressionAtlas; P14920; baseline and differential.
DR   Genevisible; P14920; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005782; C:peroxisomal matrix; TAS:Reactome.
DR   GO; GO:0005778; C:peroxisomal membrane; IDA:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0048037; F:cofactor binding; IDA:UniProtKB.
DR   GO; GO:0003884; F:D-amino-acid oxidase activity; IDA:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IDA:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IDA:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0055130; P:D-alanine catabolic process; IDA:UniProtKB.
DR   GO; GO:0036088; P:D-serine catabolic process; IDA:UniProtKB.
DR   GO; GO:0070178; P:D-serine metabolic process; IDA:UniProtKB.
DR   GO; GO:0042416; P:dopamine biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0046487; P:glyoxylate metabolic process; TAS:Reactome.
DR   GO; GO:0006562; P:proline catabolic process; IDA:UniProtKB.
DR   InterPro; IPR006181; D-amino_acid_oxidase_CS.
DR   InterPro; IPR023209; DAO.
DR   InterPro; IPR006076; FAD-dep_OxRdtase.
DR   PANTHER; PTHR11530; PTHR11530; 1.
DR   Pfam; PF01266; DAO; 1.
DR   PIRSF; PIRSF000189; D-aa_oxidase; 1.
DR   PROSITE; PS00677; DAO; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; FAD; Flavoprotein; Oxidoreductase;
KW   Peroxisome; Reference proteome.
FT   CHAIN         1    347       D-amino-acid oxidase.
FT                                /FTId=PRO_0000162761.
FT   NP_BIND       3     17       FAD. {ECO:0000269|PubMed:17088322,
FT                                ECO:0000269|PubMed:18455394}.
FT   NP_BIND      37     38       FAD. {ECO:0000269|PubMed:17088322,
FT                                ECO:0000269|PubMed:18455394}.
FT   NP_BIND      44     45       FAD. {ECO:0000269|PubMed:17088322,
FT                                ECO:0000269|PubMed:18455394}.
FT   NP_BIND      49     51       FAD. {ECO:0000269|PubMed:17088322,
FT                                ECO:0000269|PubMed:18455394}.
FT   NP_BIND     312    317       FAD. {ECO:0000269|PubMed:17088322,
FT                                ECO:0000269|PubMed:18455394}.
FT   MOTIF       345    347       Microbody targeting signal.
FT   BINDING      53     53       Substrate.
FT   BINDING     164    164       FAD; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000269|PubMed:17088322,
FT                                ECO:0000269|PubMed:18455394}.
FT   BINDING     182    182       FAD. {ECO:0000269|PubMed:17088322,
FT                                ECO:0000269|PubMed:18455394}.
FT   BINDING     217    217       Substrate.
FT   BINDING     228    228       Substrate.
FT   BINDING     283    283       Substrate.
FT   BINDING     313    313       Substrate; via carbonyl oxygen.
FT   CONFLICT     31     31       D -> H (in Ref. 1; CAA31614).
FT                                {ECO:0000305}.
FT   CONFLICT    279    279       R -> A (in Ref. 1; CAA31614).
FT                                {ECO:0000305}.
FT   STRAND        2      6       {ECO:0000244|PDB:3ZNN}.
FT   HELIX        10     23       {ECO:0000244|PDB:3ZNN}.
FT   STRAND       25     28       {ECO:0000244|PDB:3ZNN}.
FT   STRAND       31     37       {ECO:0000244|PDB:3ZNN}.
FT   HELIX        40     42       {ECO:0000244|PDB:3G3E}.
FT   HELIX        44     47       {ECO:0000244|PDB:3ZNN}.
FT   HELIX        63     77       {ECO:0000244|PDB:3ZNN}.
FT   TURN         78     80       {ECO:0000244|PDB:3ZNN}.
FT   HELIX        84     87       {ECO:0000244|PDB:3ZNN}.
FT   STRAND       89    100       {ECO:0000244|PDB:3ZNN}.
FT   TURN        106    110       {ECO:0000244|PDB:3ZNN}.
FT   STRAND      111    116       {ECO:0000244|PDB:3ZNN}.
FT   HELIX       119    122       {ECO:0000244|PDB:3ZNN}.
FT   STRAND      129    139       {ECO:0000244|PDB:3ZNN}.
FT   HELIX       141    154       {ECO:0000244|PDB:3ZNN}.
FT   STRAND      158    161       {ECO:0000244|PDB:3ZNN}.
FT   HELIX       167    172       {ECO:0000244|PDB:3ZNN}.
FT   STRAND      176    180       {ECO:0000244|PDB:3ZNN}.
FT   HELIX       183    188       {ECO:0000244|PDB:3ZNN}.
FT   STRAND      196    206       {ECO:0000244|PDB:3ZNN}.
FT   STRAND      212    216       {ECO:0000244|PDB:3ZNN}.
FT   TURN        219    221       {ECO:0000244|PDB:3ZNN}.
FT   STRAND      228    231       {ECO:0000244|PDB:3ZNN}.
FT   STRAND      233    239       {ECO:0000244|PDB:3ZNN}.
FT   HELIX       253    266       {ECO:0000244|PDB:3ZNN}.
FT   HELIX       268    272       {ECO:0000244|PDB:3ZNN}.
FT   STRAND      274    285       {ECO:0000244|PDB:3ZNN}.
FT   STRAND      290    296       {ECO:0000244|PDB:3ZNN}.
FT   STRAND      298    301       {ECO:0000244|PDB:3ZNN}.
FT   STRAND      303    309       {ECO:0000244|PDB:3ZNN}.
FT   HELIX       312    314       {ECO:0000244|PDB:4QFC}.
FT   HELIX       315    336       {ECO:0000244|PDB:3ZNN}.
SQ   SEQUENCE   347 AA;  39474 MW;  A508E603872F3072 CRC64;
     MRVVVIGAGV IGLSTALCIH ERYHSVLQPL DIKVYADRFT PLTTTDVAAG LWQPYLSDPN
     NPQEADWSQQ TFDYLLSHVH SPNAENLGLF LISGYNLFHE AIPDPSWKDT VLGFRKLTPR
     ELDMFPDYGY GWFHTSLILE GKNYLQWLTE RLTERGVKFF QRKVESFEEV AREGADVIVN
     CTGVWAGALQ RDPLLQPGRG QIMKVDAPWM KHFILTHDPE RGIYNSPYII PGTQTVTLGG
     IFQLGNWSEL NNIQDHNTIW EGCCRLEPTL KNARIIGERT GFRPVRPQIR LEREQLRTGP
     SNTEVIHNYG HGGYGLTIHW GCALEAAKLF GRILEEKKLS RMPPSHL
//
